News & Articles
COVID-19: what we know about the new variant
The virus that causes COVID-19, SARS-CoV-2, is a type of coronavirus, a large family of viruses named for the crown-like spikes on their surfaces. SARS-CoV-2 is a large RNA virus made up of around 30,000 nucleotides. A feature of RNA [...]
Prime Minister Trudeau Mention of Galenvs Sciences in His Address to Canadians
“We are also working very hard to ensure that hospitals and front-line workers have the equipment and supplies they need. And I have some good news to share on that front. First, our government signed an agreement with Montréal-based Galenvs to [...]
Galenvs Sciences Wins Innovative Solutions Canada Phase 1 Award
Galenvs Sciences is pleased to announce that the company was awarded Phase 1 funding to answer one of the challenges proposed by Innovative Solutions Canada: Magnetic reagents for detection of COVID-19 and other RNA based molecular diagnostic kits challenge. Innovative Solution [...]